Journal of Clinical Investigation · 1979 · 55 citations · 21 references
Life SciencesGeneticsMolecular GeneticsBiochemical GeneticsHuman GeneticsMedical GeneticsAnemiaHematologic DisordersRed Blood Cell DisordersSickle Cell DiseaseBeta-thalassemia In NewbornsHemoglobin LevelsMolecular Diagnosis Of HemoglobinopathiesSickle Cell Anemia
A further study of the Tgamma-chain in a variety of conditions has revealed its presence in the cord bloods of ethnic groups previously unstudied. Heterozygous newborn average 17-19% Tgamma-chain while the mean value in four presumed homozygotes was 31%. The Tgamma-chain is readily detectable in beta-thalassemia of various ethnic groups (although infrequent in Blacks) as well as in deltabeta-thalassemia. Studies of a few families have provided an opportunity to determine whether or not certain individuals are heterozygous or homozygous for the Tgamma-gene. The Tgamma-chain has not been detected in the human fetal hemoglobin that is synthesized in increased amounts in persons with the hereditary persistence of fetal hemoglobin. Although the Tgamma-chain is detectable in sickle cell anemia, its frequency appears to be lower than in normal individuals. By focusing upon the relationship of the percentage of Tgamma-chain to the sources of human fetal globulin from determinants in cis and in trans, the conclusion has been reached that the Tgamma-chain is the product of a mutant Agamma-locus which should be named the TAgamma-chain.
21
T. H. J. Huisman, W. A. Schroeder, Georgi D. Efremov et al. · Annals of the New York Academy of Sciences · 1974 · 165 citations
Medicine, Biochemistry, Hematology +12
T. H. J. Huisman, W. A. Schroeder, Andrée M. Dozy et al. · Annals of the New York Academy of Sciences · 1969 · 82 citations
Hemoglobin Kenya, the product of a gamma-beta fusion gene: studies of the family.
A. G. Kendall, Peter Ojwang, W. A. Schroeder et al. · PubMed · 1973 · 69 citations